"Executive Summary Alkaloid Based Drugs Market : Data Bridge Market Research analyses that the global alkaloid based drugs market which was USD 2.78 Billion in 2022, would rocket up to USD 5,65 Billion by 2030, and is expected to undergo a CAGR of 6.9% during the forecast period. This indicates that the market value. This Alkaloid Based Drugs Market report provides key statistics...

    The landscape of treating Mucopolysaccharidosis Type I has experienced remarkable advancement, evolving from an era of limited therapeutic options to a sophisticated array of treatment modalities that target the disease at multiple levels. This rare lysosomal storage disorder, characterized by alpha-L-iduronidase deficiency, presents unique clinical challenges that have catalyzed...

    Mucopolysaccharidosis Type I (MPS I) represents one of the most challenging genetic disorders, affecting approximately 1 in 100,000 births worldwide. This lysosomal storage disease occurs when the body lacks sufficient alpha-L-iduronidase enzyme, leading to the accumulation of glycosaminoglycans in various tissues and organs. While current treatments like enzyme replacement...